Teva- Pharmaceutical Industries Overview

Teva- Pharmaceutical Industries Other Income Expense Net

Other Income/Expense Net for TEVA.

Quarterly Other Income/Expense

-$216.00M

↑ 4% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$928.00M

↑ 47.75% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin